Pyruvate carboxylase (PC) is a mitochondrial, biotin-containing enzyme catalyzing the ATP-dependent synthesis of oxaloacetate from pyruvate and bicarbonate, with a critical anaplerotic role in sustaining the brain metabolism. Based on the studies performed on animal models, PC expression was assigned to be glia-specific. To study PC distribution among human neural cells, we probed the cultured human astrocytes and brain sections with antibodies against PC. Additionally, we tested the importance of PC for the viability of cultured human astrocytes by applying the PC inhibitor 3-chloropropane-1,2-diol (CPD). Our results establish the expression of PC in mitochondria of human astrocytes in culture and brain tissue and also into a subpopulation of the neurons in situ. CPD negatively affected the viability of astrocytes in culture, which could be partially reversed by supplementing media with malate, 2-oxoglutarate, citrate, or pyruvate. The provided data estimates PC expression in human astrocytes and neurons in human brain parenchyma. Furthermore, the enzymatic activity of PC is vital for sustaining the viability of cultured astrocytes.

Department of Medical Biochemistry Jessenius Faculty of Medicine in Martin Comenius University in Bratislava Martin Slovak Republic

Zobrazit více v PubMed

Inigo M, Deja S, Burgess SC. Ins and outs of the TCA cycle: the central role of anaplerosis. Annu Rev Nutr. 2021;41:19–47. doi: 10.1146/annurev-nutr-120420-025558. PubMed DOI

Owen OE, Kalhan SC, Hanson RW. The key role of anaplerosis and cataplerosis for citric acid cycle function. J Biol Chem. 2002;277:30409–30412. doi: 10.1074/jbc.R200006200. PubMed DOI

LAJTHA A, GIBSON GE, DIENEL GA, editors. Handbook of Neurochemistry and Molecular Neurobiology. Springer; US, Boston, MA: 2007. Hassel B: 3.1 Anaplerosis; pp. 183–195. DOI

Schousboe A, Waagepetersen HS, Sonnewald U. Astrocytic pyruvate carboxylation: Status after 35 years. J Neurosci Res. 2019;97:890–896. doi: 10.1002/jnr.24402. PubMed DOI

Wang D, De Vivo D. Pyruvate carboxylase deficiency. In: ADAM MP, ARDINGER HH, PAGON RA, et al., editors. GeneReviews®. University of Washington; Seattle, Seattle (WA): 1993.

Brun N, Robitaille Y, Grignon A, Robinson BH, Mitchell GA, Lambert M. Pyruvate carboxylase deficiency: prenatal onset of ischemia-like brain lesions in two sibs with the acute neonatal form. Am J Med Genet. 1999;84:94–101. doi: 10.1002/(SICI)1096-8628(19990521)84:2<94::AID-AJMG3>3.0.CO;2-1. PubMed DOI

García-Cazorla A, Rabier D, Touati G, Chadefaux-Vekemans B, Marsac C, de Lonlay P, Saudubray J-M. Pyruvate carboxylase deficiency: metabolic characteristics and new neurological aspects. Ann Neurol. 2006;59:121–127. doi: 10.1002/ana.20709. PubMed DOI

Hidalgo J, Campoverde L, Ortiz JF, Ruxmohan S, Eissa-Garcés A. A unique case of pyruvate carboxylase deficiency. Cureus. 2021;13:e15042. doi: 10.7759/cureus.15042. PubMed DOI PMC

Mhanni AA, Rockman-Greenberg C, Ryner L, Bunge M. Prenatal onset of the neuroradiologic phenotype of pyruvate carboxylase deficiency due to homozygous PC c.1828G > A mutations. JIMD Rep. 2021;61:42–47. doi: 10.1002/jmd2.12235. PubMed DOI PMC

Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, Rabier D, Roe CR, Saudubray J-M. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab. 2005;84:305–312. doi: 10.1016/j.ymgme.2004.09.007. PubMed DOI

Monnot S, Serre V, Chadefaux-Vekemans B, Aupetit J, Romano S, De Lonlay P, Rival J-M, et al. Structural insights on pathogenic effects of novel mutations causing pyruvate carboxylase deficiency. Hum Mutat. 2009;30:734–740. doi: 10.1002/humu.20908. PubMed DOI

Schiff M, Levrat V, Acquaviva C, Vianey-Saban C, Rolland M-O, Guffon N. A case of pyruvate carboxylase deficiency with atypical clinical and neuroradiological presentation. Mol Genet Metab. 2006;87:175–177. doi: 10.1016/j.ymgme.2005.10.007. PubMed DOI

Pardridge WM. Brain metabolism: a perspective from the blood-brain barrier. Physiol Rev. 1983;63:1481–1535. doi: 10.1152/physrev.1983.63.4.1481. PubMed DOI

Gruetter R, Novotny EJ, Boulware SD, Mason GF, Rothman DL, Shulman GI, Prichard JW, Shulman RG. Localized 13C NMR spectroscopy in the human brain of amino acid labeling from D-[1-13C]glucose. J Neurochem. 1994;63:1377–1385. doi: 10.1046/j.1471-4159.1994.63041377.x. PubMed DOI

Hertz L, Chen Y. Integration between glycolysis and glutamate-glutamine cycle flux may explain preferential glycolytic increase during brain activation, requiring glutamate. Front Integr Neurosci. 2017;11:18. doi: 10.3389/fnint.2017.00018. PubMed DOI PMC

Gray LR, Tompkins SC, Taylor EB. Regulation of pyruvate metabolism and human disease. Cell Mol Life Sci. 2014;71:2577–2604. doi: 10.1007/s00018-013-1539-2. PubMed DOI PMC

Shank RP, Bennett GS, Freytag SO, Campbell GL. Pyruvate carboxylase: an astrocyte-specific enzyme implicated in the replenishment of amino acid neurotransmitter pools. Brain Res. 1985;329:364–367. doi: 10.1016/0006-8993(85)90552-9. PubMed DOI

Shank RP, Leo GC, Zielke HR. Cerebral metabolic compartmentation as revealed by nuclear magnetic resonance analysis of D-[1-13C]glucose metabolism. J Neurochem. 1993;61:315–323. doi: 10.1111/j.1471-4159.1993.tb03570.x. PubMed DOI

Cesar M, Hamprecht B. Immunocytochemical examination of neural rat and mouse primary cultures using monoclonal antibodies raised against pyruvate carboxylase. J Neurochem. 1995;64:2312–2318. doi: 10.1046/j.1471-4159.1995.64052312.x. PubMed DOI

Murín R, Cesar M, Kowtharapu BS, Verleysdonk S, Hamprecht B. Expression of pyruvate carboxylase in cultured oligodendroglial, microglial and ependymal cells. Neurochem Res. 2009;34:480–489. doi: 10.1007/s11064-008-9806-6. PubMed DOI

Amaral AI, Hadera MG, Tavares JM, Kotter MRN, Sonnewald U. Characterization of glucose-related metabolic pathways in differentiated rat oligodendrocyte lineage cells. Glia. 2016;64:21–34. doi: 10.1002/glia.22900. PubMed DOI PMC

Salganicoff L, Koeppe RE. Subcellular distribution of pyruvate carboxylase, diphosphopyridine nucleotide and triphosphopyridine nucleotide isocitrate dehydrogenases, and malate enzyme in rat brain. J Biol Chem. 1968;243:3416–3420. doi: 10.1016/S0021-9258(18)93324-7. PubMed DOI

Hassel B. Carboxylation and anaplerosis in neurons and glia. Mol Neurobiol. 2000;22:21–40. doi: 10.1385/MN:22:1-3:021. PubMed DOI

Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254. doi: 10.1006/abio.1976.9999. PubMed DOI

Gondáš E, Král’ová Trančíková A, Majerčíková Z, Pokusa M, Baranovičová E, Bystrický P, Dobrota D, Murín R. Expression of pyruvate carboxylase in cultured human astrocytoma, glioblastoma and neuroblastoma cells. Gen Physiol Biophys. 2021;40:127–135. doi: 10.4149/gpb_2021003. PubMed DOI

Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63. doi: 10.1016/0022-1759(83)90303-4. PubMed DOI

Warren GB, Tipton KF. Pig liver pyruvate carboxylase. Purification, properties and cation specificity. Biochem J. 1974;139:297–310. doi: 10.1042/bj1390297. PubMed DOI PMC

Gondáš E, Král’ová Trančíková A, Dibdiaková K, Galanda T, Hatok J, Račay P, Dobrota D, Murín R. Immunodetection of pyruvate carboxylase expression in human astrocytomas, glioblastomas, oligodendrogliomas, and meningiomas. Neurochem Res. 2023;48:1728–1736. doi: 10.1007/s11064-023-03856-5. PubMed DOI PMC

Doedens D, Ashmore J. Inhibition of pyruvate carboxylase by chloropyruvic acid and related compounds. Biochem Pharmacol. 1972;21:1745–1751. doi: 10.1016/0006-2952(72)90081-0. PubMed DOI

Zeczycki TN, St Maurice M, Attwood PV. Inhibitors of pyruvate carboxylase. Open Enzyme Inhib J. 2010;3:8–26. doi: 10.2174/1874940201003010008. PubMed DOI PMC

Atkin BM, Buist NRM, Utter MF, Leiter AB, Banker BQ. Pyruvate carboxylase deficiency and lactic acidosis in a retarded child without Leigh’s disease. Pediatr Res. 1979;13:109–116. doi: 10.1203/00006450-197902000-00005. PubMed DOI

Zhang Z, Ma Z, Zou W, Guo H, Liu M, Ma Y, Zhang L. The appropriate marker for astrocytes: comparing the distribution and expression of three astrocytic markers in different mouse cerebral regions. Biomed Res Int. 2019;2019:1–15. doi: 10.1155/2019/9605265. PubMed DOI PMC

Yu AC, Drejer J, Hertz L, Schousboe A. Pyruvate carboxylase activity in primary cultures of astrocytes and neurons. J Neurochem. 1983;41:1484–1487. doi: 10.1111/j.1471-4159.1983.tb00849.x. PubMed DOI

Yuan A, Rao MV, Veeranna Nixon RA. Neurofilaments and neurofilament proteins in health and disease. Cold Spring Harb Perspect Biol. 2017;9:a018309. doi: 10.1101/cshperspect.a018309. PubMed DOI PMC

Hassel B, Bråthe A. Neuronal pyruvate carboxylation supports formation of transmitter glutamate. J Neurosci. 2000;20:1342–1347. doi: 10.1523/JNEUROSCI.20-04-01342.2000. PubMed DOI PMC

Hassel B, Bråthe A. Cerebral metabolism of lactate in vivo: evidence for neuronal pyruvate carboxylation. J Cereb Blood Flow Metab. 2000;20:327–336. doi: 10.1097/00004647-200002000-00014. PubMed DOI

Jitrapakdee S, St Maurice M, Rayment I, Wallace Cleland W, Wallace JC, Attwood PV. Structure, mechanism and regulation of pyruvate carboxylase. Biochem J. 2008;413:369–387. doi: 10.1042/BJ20080709. PubMed DOI PMC

Cappel DA, Deja S, Duarte JAG, Kucejova B, Iñigo M, Fletcher JA, Fu X, et al. Pyruvate-carboxylase-mediated anaplerosis promotes antioxidant capacity by sustaining TCA cycle and redox metabolism in liver. Cell Metab. 2019;29:1291–1305.e8. doi: 10.1016/j.cmet.2019.03.014. PubMed DOI PMC

Martínez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102. doi: 10.1038/s41467-019-13668-3. PubMed DOI PMC

Martin-Requero A, Ayuso MS, Parrilla R. Interaction of oxamate with the gluconeogenic pathway in rat liver. Arch Biochem Biophys. 1986;246:114–127. doi: 10.1016/0003-9861(86)90455-8. PubMed DOI

Zhai X, Yang Y, Wan J, Zhu J, Wu Y. Inhibition of LDH-A by oxamate induces G2/M arrest, apoptosis and increases radiosensitivity in nasopharyngeal carcinoma cells. Oncol Rep. 2013;30:2983–2991. doi: 10.3892/or.2013.2735. PubMed DOI

Thornburg JM, Nelson KK, Clem BF, Lane AN, Arumugam S, Simmons A, Eaton JW, Telang S, Chesney J. Targeting aspartate aminotransferase in breast cancer. Breast Cancer Res. 2008;10:R84. doi: 10.1186/bcr2154. PubMed DOI PMC

Oz G, Berkich DA, Henry P-G, Xu C, LaNoue K, Hutson SM, Gruetter R. Neuroglial metabolism in the awake rat brain: CO2 fixation increases with brain activity. J Neurosci. 2004;24:11273–11279. doi: 10.1523/JNEUROSCI.3564-04.2004. PubMed DOI PMC

Andersen JV, Markussen KH, Jakobsen E, Schousboe A, Waagepetersen HS, Rosenberg PA, Aldana BI. Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration. Neuropharmacology. 2021;196:108719. doi: 10.1016/j.neuropharm.2021.108719. PubMed DOI

Andersen JV, Christensen SK, Westi EW, Diaz-delCastillo M, Tanila H, Schousboe A, Aldana BI, Waagepetersen HS. Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer’s disease. Neurobiol Dis. 2021;148:105198. doi: 10.1016/j.nbd.2020.105198. PubMed DOI

Barber CN, Raben DM. Lipid metabolism crosstalk in the brain: glia and neurons. Front Cell Neurosci. 2019;13:212. doi: 10.3389/fncel.2019.00212. PubMed DOI PMC

Zhang J, Liu Q. Cholesterol metabolism and homeostasis in the brain. Protein Cell. 2015;6:254–264. doi: 10.1007/s13238-014-0131-3. PubMed DOI PMC

Jin U, Park SJ, Park SM. Cholesterol metabolism in the brain and its association with Parkinson’s disease. Exp Neurobiol. 2019;28:554–567. doi: 10.5607/en.2019.28.5.554. PubMed DOI PMC

Dietschy JM, Turley SD. Cholesterol metabolism in the brain. Curr Opin Lipidol. 2001;12:105–112. doi: 10.1097/00041433-200104000-00003. PubMed DOI

Aspartate in the Brain: A Review